Patents Assigned to QuiaPEG Pharmaceuticals AB
  • Patent number: 11382984
    Abstract: This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: July 12, 2022
    Assignee: QUIAPEG PHARMACEUTICALS AB
    Inventor: Marek Kwiatkowski
  • Patent number: 11357828
    Abstract: The present application provides compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein D is a residue of a GLP-polypeptide or an analog thereof, which underdo hydrolysis under physiological conditions to release the GLP-polypeptide or analog thereof and which are useful in the treatment of disorders that could be beneficially treated with the GLP-polypeptide or analog thereof.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: June 14, 2022
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventors: Marek Kwiatkowski, Christian Sund
  • Patent number: 10973921
    Abstract: This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: April 13, 2021
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10806796
    Abstract: This document relates to conjugates of a biologically active molecule or a derivative thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: October 20, 2020
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10781286
    Abstract: This document relates to functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such functionalized polymers.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: September 22, 2020
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10653788
    Abstract: This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: May 19, 2020
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10383946
    Abstract: This document relates to conjugates of a biologically active molecule or a derivative thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: August 20, 2019
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10207007
    Abstract: This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: February 19, 2019
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10125220
    Abstract: This document relates to functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such functionalized polymers.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: November 13, 2018
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 10010621
    Abstract: This document relates to conjugates of a biologically active molecule or a derivative thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: July 3, 2018
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 9849187
    Abstract: This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: December 26, 2017
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski
  • Patent number: 9220789
    Abstract: This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: December 29, 2015
    Assignee: QuiaPEG Pharmaceuticals AB
    Inventor: Marek Kwiatkowski